Streetbeat News

Stock Prices

SEDG

Piper Sandler analyst Kashy Harrison downgraded SolarEdge Technologies (NASDAQ:SEDG) from Overweight to Neutral and reduced the price target from $110 to $105.

Portfolio Pulse from Benzinga Newsdesk

December 19, 2023 | 12:13 pm

ARRY

Piper Sandler analyst Kashy Harrison downgraded Array Technologies (ARRY) from Overweight to Neutral and reduced the price target from $26 to $22.

Portfolio Pulse from Benzinga Newsdesk

December 19, 2023 | 12:11 pm

ZWS

Stifel analyst Nathan Jones has downgraded Zurn Elkay Water (NYSE:ZWS) from Buy to Hold and set a price target of $31. This change reflects a more cautious stance on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

December 19, 2023 | 12:09 pm

DOOR

Baird analyst Timothy Wojs downgraded Masonite International (NYSE:DOOR) from Outperform to Neutral and reduced the price target from $106 to $92.

Portfolio Pulse from Benzinga Newsdesk

December 19, 2023 | 12:06 pm

ROK

Wells Fargo analyst Joe O'Dea has upgraded Rockwell Automation (NYSE:ROK) from Equal-Weight to Overweight and set a price target of $357.

Portfolio Pulse from Benzinga Newsdesk

December 19, 2023 | 12:04 pm

ARVN

Wells Fargo analyst Derek Archila has upgraded Arvinas (NASDAQ:ARVN) from Equal-Weight to Overweight and set a price target of $63.

Portfolio Pulse from Benzinga Newsdesk

December 19, 2023 | 12:02 pm

WVE

Leerink Partners analyst Mani Foroohar has upgraded WAVE Life Sciences (NASDAQ:WVE) from Market Perform to Outperform and set a price target of $12.

Portfolio Pulse from Benzinga Newsdesk

December 19, 2023 | 12:00 pm

CHWY

OLMA

TSE

WFCF

Insiders at Olema Pharmaceuticals, Trinseo, Where Food Comes From, and Chewy have recently made significant stock purchases. Olema Pharmaceuticals Director Graham Walsmley acquired 640,000 shares for about $6.87 million. Trinseo Director Matthew Farrell bought 50,000 shares for $360,500. Where Food Comes From Director Pete Lapaseotes purchased 1,438 shares for $18,334. Chewy Director James A Star acquired 12,242 shares for approximately $249,519. These purchases may indicate insider confidence despite varying company news, such as FDA warnings for Chewy and poor quarterly results for Trinseo.

Portfolio Pulse from Avi Kapoor

December 19, 2023 | 11:59 am

ITRI

Piper Sandler analyst Kashy Harrison upgraded Itron (NASDAQ:ITRI) from Neutral to Overweight and increased the price target from $72 to $91.

Portfolio Pulse from Benzinga Newsdesk

December 19, 2023 | 11:52 am

ACN

Accenture projects its Q2FY24 revenues to be between $15.40B and $16B, which is below the consensus estimate of $16.25B. The forecasted revenue growth is expected to be between negative 2% to 2% in local currency.

Portfolio Pulse from Benzinga Newsdesk

December 19, 2023 | 11:51 am